Subcellular Localization of Activated AKT in Estrogen Receptor- and Progesterone Receptor-Expressing Breast Cancers
- 1 May 2010
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 176 (5) , 2139-2149
- https://doi.org/10.2353/ajpath.2010.090477
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (CA107300, CA90571, CA89153)
This publication has 61 references indexed in Scilit:
- Akt Determines Replicative Senescence and Oxidative or Oncogenic Premature Senescence and Sensitizes Cells to Oxidative ApoptosisCancer Cell, 2008
- A transforming mutation in the pleckstrin homology domain of AKT1 in cancerNature, 2007
- AKT/PKB Signaling: Navigating DownstreamCell, 2007
- Genome-wide analysis of estrogen receptor binding sitesNature Genetics, 2006
- Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer StudyJAMA, 2006
- Identification of a tumour suppressor network opposing nuclear Akt functionNature, 2006
- Nuclear Akt associates with PKC-phosphorylated Ebp1, preventing DNA fragmentation by inhibition of caspase-activated DNaseThe EMBO Journal, 2006
- Perturbations of the AKT signaling pathway in human cancerOncogene, 2005
- Chromosome-Wide Mapping of Estrogen Receptor Binding Reveals Long-Range Regulation Requiring the Forkhead Protein FoxA1Cell, 2005
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerNew England Journal of Medicine, 2002